Clinical factors predictive of myelofibrotic evolution in patients with polycythemia vera

被引：0
|
作者：
Mario Tiribelli
Daniela Barraco
Federico De Marchi
Luciana Marin
Marta Medeot
Daniela Damiani
Renato Fanin
机构：
[1] Azienda Ospedialiero-Universitaria di Udine,Division of Hematology and BMT, Department of Experimental and Clinical Medical Sciences
来源：
Annals of Hematology | 2015年 / 94卷
关键词：
Acute Myeloid Leukemia; Myeloid Leukemia; Cardiovascular Risk Factor; Cumulative Incidence; Polycythemia Vera;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：873 / 874
页数：1
相关论文
共 50 条
  • [11] JAK2V617F MONITORING IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA: CLINICAL USEFULNESS FOR PREDICTING MYELOFIBROTIC TRANSFORMATION
    Alvarez-Larran, A.
    Bellosillo, B.
    Kergelen, A.
    Hernandez-Boluda, J.
    Pereira, A.
    Longaron, R.
    Martinez-Aviles, L.
    Ancochea, A.
    Angona, A.
    Lombardia, L.
    Navarro, B.
    Collado, M.
    Montoro, J.
    Besses, C.
    HAEMATOLOGICA, 2013, 98 : 343 - 343
  • [12] In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
    Barbui, Tiziano
    Carobbio, Alessandra
    Rumi, Elisa
    Finazzi, Guido
    Gisslinger, Heinz
    Rodeghiero, Francesco
    Randi, Maria Luigia
    Rambaldi, Alessandro
    Gisslinger, Bettina
    Pieri, Lisa
    Bertozzi, Irene
    Casetti, Ilaria
    Pardanani, Animesh
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    Tefferi, Ayalew
    BLOOD, 2014, 124 (19) : 3021 - 3023
  • [13] In Contemporary Patients with Polycythemia Vera, Rates of Thrombosis and Risk Factors Delineate a New Clinical Epidemiology
    Barbui, Tiziano
    Carobbio, Alessandra
    Rumi, Elisa
    Finazzi, Guido
    Gisslinger, Heinz
    Rodeghiero, Francesco
    Randi, Maria Luigia
    Rambaldi, Alessandro
    Gisslinger, Bettina
    Pieri, Lisa
    Bertozzi, Irene
    Casetti, Ilaria Carola
    Muellauer, Leonhard
    Pardanani, Animesh
    Thiele, Juergen
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    Tefferi, Ayalew
    BLOOD, 2014, 124 (21)
  • [14] Myelofibrotic Transformations of Polycythemia Vera and Essential Thrombocythemia are Morphologically, Biologically, and Prognostically Indistinguishable From Primary Myelofibrosis
    Sangle, Nikhil
    Cook, Josh
    Perkins, Sherrie
    Teman, Carolin J.
    Bahler, David
    Hickman, Kimberly
    Wilson, Andrew
    Prchal, Josef
    Salama, Mohamed E.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (09) : 663 - 668
  • [15] POLYCYTHEMIA-VERA - CLINICAL FINDINGS AND COURSE IN 86 PATIENTS
    EGLI, F
    WIECZOREK, A
    NIEMOLLER, M
    RHYNER, K
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (52) : 1969 - 1975
  • [16] HEMATOPOIETIC FACTORS IN POLYCYTHEMIA-VERA
    ZANJANI, ED
    SEMINARS IN HEMATOLOGY, 1976, 13 (01) : 1 - 12
  • [17] Etiologic and pathologic factors in polycythemia vera
    Reznikoff, P
    Foot, NC
    Bethea, JM
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1935, 189 : 753 - 759
  • [18] POLYCYTHEMIA-VERA - A CLINICAL-STUDY OF 141 PATIENTS
    ANGER, B
    HAUG, U
    SEIDLER, R
    HEIMPEL, H
    BLUT, 1989, 59 (06): : 493 - 500
  • [19] Hypocholesterolemia in Patients with Polycythemia Vera
    Fujita, Hiroshi
    Hamaki, Tamae
    Handa, Naoko
    Ohwada, Akira
    Tomiyama, Junji
    Nishimura, Shigeko
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2012, 52 (02) : 85 - 89
  • [20] Polycythemia vera in GIST patients
    Schoeler, D.
    Kluehs, C.
    Pink, D.
    Reichardt, A.
    Reichardt, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345